U.S. flag

An official website of the United States government

NM_000245.4(MET):c.3750G>T (p.Met1250Ile) AND Neoplasm

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 26, 2014
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000419338.1

Allele description [Variation Report for NM_000245.4(MET):c.3750G>T (p.Met1250Ile)]

NM_000245.4(MET):c.3750G>T (p.Met1250Ile)

Gene:
MET:MET proto-oncogene, receptor tyrosine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000245.4(MET):c.3750G>T (p.Met1250Ile)
HGVS:
  • NC_000007.14:g.116783421G>T
  • NG_008996.1:g.116017G>T
  • NM_000245.4:c.3750G>TMANE SELECT
  • NM_001127500.3:c.3804G>T
  • NM_001324402.2:c.2460G>T
  • NP_000236.2:p.Met1250Ile
  • NP_001120972.1:p.Met1268Ile
  • NP_001311331.1:p.Met820Ile
  • LRG_662:g.116017G>T
  • NC_000007.13:g.116423475G>T
Protein change:
M1250I
Links:
dbSNP: rs121913676
NCBI 1000 Genomes Browser:
rs121913676
Molecular consequence:
  • NM_000245.4:c.3750G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127500.3:c.3804G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001324402.2:c.2460G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Neoplasm
Synonyms:
Neoplasms; Neoplasm (disease)
Identifiers:
MONDO: MONDO:0005070; MeSH: D009369; MedGen: C0027651; Human Phenotype Ontology: HP:0002664

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000505280Database of Curated Mutations (DoCM)
no assertion criteria provided
Likely pathogenic
(Dec 26, 2014)
somaticliterature only

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.

Zou HY, Li Q, Lee JH, Arango ME, McDonnell SR, Yamazaki S, Koudriakova TB, Alton G, Cui JJ, Kung PP, Nambu MD, Los G, Bender SL, Mroczkowski B, Christensen JG.

Cancer Res. 2007 May 1;67(9):4408-17.

PubMed [citation]
PMID:
17483355

Details of each submission

From Database of Curated Mutations (DoCM), SCV000505280.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022